Global Biosimilars WeekGlobal Biosimilars Week

  • About
  • Basics
  • Approvals
  • Benefits
  • Experience
  • Future
  • Social Media
  • Resources

Global Biosimilars Week

MENU

Press Enter To Begin Your Search

Biosimilar medicines in the EU

What is a biosimilar? How does EMA works to ensure that these biological medicines are as safe and effective as any other medicines? Watch our new video and check the biosimilar guide for healthcare professionals to find out.

ORGANIZATION:

RESOURCE TYPE:
VIDEO

ENGLISH VERSION FRENCH VERSION SPANISH VERSION PORTUGUESE VERSION
Skills

Videos

0

White Paper: Breaking Through on Biosimilars

Reports

Biosimilars or Biologics: What’s the difference?

Factsheets

CONTACT US
IGBA | INTERNATIONAL GENERIC AND BIOSIMILAR MEDICINES ASSOCIATION
C/O DYN SA - Rue de Cornavin 11 - 1201 Geneva, Switzerland - Telephone: +32 (0)2 5346607 (S. Kox)
E-mails: info@igbamedicines.org / skox@igbamedicines.org (Secretary General)
© 2020 International Generic and Biosimilar Medicines Association (IGBA), All Rights Reserved. For more information, contact IGBA